NCT00820885 - A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 6, 2006

Primary Completion Date

April 23, 2007

Study Completion Date

April 23, 2007

Conditions

Pharmacokinetics and Safety of Elevated Doses

Interventions

DRUG

teduglutide

subcutaneous injection given once a day in the abdomen. Drug is lypholized powder.

DRUG

teduglutide

Once daily subcutaneous injection in the abdomen. Drug is lypholized powder reconstituted with sterile water

DRUG

tedguglutide

lypholized powder reconstituted with sterile water and injection subcutaneously once a day in the abdomen.

Trial Locations (1)

Northwest Kinetics, Tacoma